Search results
'It's part of me, it's not me': North Oconee senior doesn't let POTS diagnosis define her
Athens Banner-Herald via Yahoo Sports· 1 day agoShe had postural orthostatic tachycardia syndrome, commonly referred to as POTS. Because POTS is a neurological disorder that affects blood flow and the autonomic ...
The health condition many women are developing after COVID
MSN News· 5 days agoGuava Health explains the symptoms and effects of postural orthostatic tachycardia syndrome.
New Clinical Guidance for Sjögren-Related Neuropathy
Medscape· 6 days agoThe guidelines will provide an evidence-based resource for the assessment, diagnosis, and treatment of various peripheral neuropathies related to the ...
GABA supplementation may improve emotional health in overweight women
Nutraingredients.com· 6 days agoThe efficacy of GABA supplementation is partly measured by heart-rate variability (HRV), which is...
Vivalink introduces new solution for MCT and Holter monitoring
Medical Device Network via Yahoo Finance· 5 days agoResearch Trust (RSRT) collaborated to advance research into Rett syndrome, a rare neurological ...
National Institutes of Health (NIH) to Open Long COVID Clinical Trials to Study Sleep Disturbances,...
Sierra Sun Times· 4 days agoThe mid-stage trials, part of NIH’s Researching COVID to Enhance Recovery (RECOVER) Initiative, will join six other RECOVER studies currently enrolling participants across the United States ...
Why sleep soothes distress: Neurobiology explained
Medical Xpress· 7 days agoA study published in Nature Reviews Neuroscience by an international team including the Woolcock's Dr. Rick Wassing examined research into sleep disorders over more than two ...
Data Underscore Negative Health Effects of Traffic Noise
Medscape· 1 day agoNew research by Thomas Münzel, MD, senior professor of cardiology at Johannes Gutenberg University...
Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
WTNH-TV New Haven· 15 hours agoTheravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced financial and operational results for the first quarter of 2024. "Building on recent momentum ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 6 days agoAlterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...